Ova Donation for Stem Cell Research: An International Perspective

Should clinicians ask women to donate or even sell their eggs for stem cell research? Enucleated ova are crucial in somatic cell nuclear transfer technologies, but risky for women's health. Until comparatively recently, very few commentators debated the ethical issues in egg donation and sale, concentrating on the embryo's status. The unmasking of Hwang Woo Suk, who used over 2,200 ova in his fraudulent research, has finally brought the question of ova donation and sale into prominence. In this article we offer an international comparison of recent responses to this crucial question and suggest that the levels of risk are too imprecise to enable women to give meaningful informed consent for egg extraction. What we do know of the risks also indicates that they are too high and that potential donors or sellers are not being fully informed of their extent, raising disturbing ethical issues concerning commodification, deception, coercion, and exploitation.

[1]  Guidelines for the conduct of human embryonic stem cell research. , 2009, Current protocols in stem cell biology.

[2]  A. Balen.  The Human Fertilisation and Embryology Authority (HFEA) , 2008 .

[3]  B. Dickens.  International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006). , 2008, Medicine and law.

[4]  Donna Dickenson,et al.  Body Shopping: The Economy Fuelled by Flesh and Blood , 2008 .

[5]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[6]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[7]  D. Spar.  The egg trade--making sense of the market for human oocytes. , 2007, The New England journal of medicine.

[8]  Charis M. Thompson.  Why we should, in fact, pay for egg donation. , 2007, Regenerative medicine.

[9]  Jan Passchier,et al.  A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial , 2007, The Lancet.

[10]  D. Dickenson.  Property in the Body , 2007 .

[11]  Border Ireland,et al.  Health and Consumer Protection Directorate - General, European commission , 2007 .

[12]  D. Dickenson.  Property in the Body: Index , 2007 .

[13]  B. Heng.  The advent of international ‘mail‐order’ egg donation , 2006, BJOG : an international journal of obstetrics and gynaecology.

[14]  Emily Jackson.  Fraudulent Stem Cell Research and Respect for the Embryo , 2006 .

[15]  I. Hyun.  Fair payment or undue inducement? , 2006, Nature.

[16]  H. Pearson.  Health effects of egg donation may take decades to emerge , 2006, Nature.

[17]  E. Check.  Ethicists and biologists ponder the price of eggs , 2006, Nature.

[18]  D. Dickenson.  The Lady Vanishes: What’s Missing from the Stem Cell Debate , 2006 .

[19]  Ingrid Schneider.  Oocyte donation for reproduction and research cloning--the perils of commodification and the need for European and international regulation. , 2006, Revista de derecho y genoma humano = Law and the human genome review.

[20]  I. Hyun.  Magic Eggs and the Frontier of Stem Cell Science , 2006, The Hastings Center report.

[21]  J. Johnston.  Paying Egg Donors: Exploring the Arguments , 2006, The Hastings Center report.

[22]  F. Galis,et al.  Evolutionary conserved structures as indicators of medical risks: increased incidence of cervical ribs after ovarian hyperstimulation in mice , 2006 .

[23]  P. Devroey,et al.  Subsidized in-vitro fertilization treatment and the effect on the number of egg sharers. , 2006, Reproductive biomedicine online.

[24]  Richard O Hynes,et al.  Guidelines for human embryonic stem cell research , 2005, Nature Biotechnology.

[25]  Jin Mee Kim,et al.  Patient-Specific Embryonic Stem Cells Derived from Human SCNT Blastocysts , 2005, Science.

[26]  M. Cho,et al.  Issues in Oocyte Donation for Stem Cell Research , 2005, Science.

[27]  Laura Meints,et al.  Umbilical Cord Blood Banking , 2011 .

[28]  J. Norsigian.  Egg Donation for IVF and Stem Cell Research: Time to Weigh the Risks to Women's Health , 2005 .

[29]  D. Dickenson.  Consent, commodification and benefit-sharing in genetic research. , 2004, Developing world bioethics.

[30]  B. Steinbock.  Payment for egg donation and surrogacy. , 2004, The Mount Sinai journal of medicine, New York.

[31]  LeRoy Walters.  Human Embryonic Stem Cell Research: An Intercultural Perspective , 2004, Kennedy Institute of Ethics journal.

[32]  Sung Keun Kang,et al.  Evidence of a Pluripotent Human Embryonic Stem Cell Line Derived from a Cloned Blastocyst , 2004, Science.

[33]  D. Dickenson.  Ethics watch: the threatened trade in human ova , 2004 .

[34]  L. Knowles.  A regulatory patchwork—human ES cell research oversight , 2004, Nature Biotechnology.

[35]  D. Dickenson.  Patently paradoxical? 'Public order' and genetic patents , 2004, Nature Reviews Genetics.

[36]  David B. Resnik,et al.  The Commercialization of Human Stem Cells: Ethical and Policy Issues , 2004, Health Care Analysis.

[37]  D. Dickenson.  Risk and Luck in Medical Ethics , 2003 .

[38]  Serge Rozenberg,et al.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. , 2002, Human reproduction update.

[39]  D. Dickenson.  Commodification of human tissue: implications for feminist and development ethics. , 2002, Developing world bioethics.

[40]  M. Marzano.  Penser le corps , 2002 .

[41]  C. Elliott.  Throwing a bone to the watchdog. , 2001, The Hastings Center report.

[42]  G. Meilaender.  The point of a ban. Or, how to think about stem cell research. , 2001, The Hastings Center report.

[43]  B. Blackwell.  Human Embryonic Stem Cell Research , 2001 .

[44]  Dott.ssa Margherita Daverio.  European Group on Ethics in Science and New Technologies. , 1998, Human reproduction and genetic ethics.

[45]  B. Lubin,et al.  Umbilical cord blood banking. , 1999, Advances in pediatrics.

[46]  Frank Launder,et al.  バルカン超特急 = The lady vanishes , 1936 .